Medicare Enrolled
Dr. William Berkery, MD
Interventional Cardiology · Syracuse, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Berkery from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Berkery?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Berkery
Dr. William Berkery is an interventional cardiology specialist in Syracuse, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Berkery performed 3,532 Medicare services across 2,117 unique beneficiaries.
Between the years covered by Open Payments, Dr. Berkery received a total of $2,044 from 28 pharmaceutical and/or device companies across 129 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in interventional cardiology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Berkery is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 13% volume in NY
$2,044 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,532
Medicare services
Top 13% in NY for interventional cardiology
2,117
Unique beneficiaries
$42
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~177 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Anticoagulant management for warfarin Management of anticoagulant therapy for a patient taking warfarin. This service involves monitoring and adjusting the medication regimen. |
903 | $8 | $24 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
735 | $93 | $209 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
630 | $10 | $40 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
341 | $6 | $17 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
139 | $61 | $142 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
94 | $60 | $162 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
78 | $101 | $266 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
77 | $149 | $409 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while an electrocardiogram is monitored under physician supervision. |
51 | $16 | $44 |
| 2-day continuous ECG monitoring A continuous electrocardiogram recording that captures heart activity over a 48-hour period. This test helps detect irregular heart rhythms or other cardiac issues that may not appear during a standard, short-term ECG. |
48 | $13 | $51 |
| 2-day continuous ECG with professional review A two-day continuous electrocardiogram recording that includes a review by a healthcare professional. |
45 | $14 | $53 |
| Programming of dual lead implantable defibrillator system Adjustment and testing of the settings for an implanted heart device with two leads to ensure proper function. |
43 | $72 | $153 |
| Echocardiogram with color Doppler An ultrasound of the heart that uses color imaging to visualize blood flow, measure flow rate, and assess valve function. |
40 | $18 | $167 |
| Echocardiogram, transthoracic An ultrasound test that uses sound waves to create images of the heart's blood flow, valves, and chambers. |
39 | $37 | $106 |
| Stress echocardiogram with ECG monitoring An ultrasound of the heart performed while monitoring heart rhythm during rest, exercise, or medication-induced stress, followed by a review and report of the findings. |
39 | $178 | $457 |
| Continuous ECG monitoring, up to 30 days Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results. |
34 | $19 | $51 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
31 | $134 | $395 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
27 | $67 | $142 |
| Evaluation of implantable heart and blood vessel monitoring system This procedure involves checking the function and data of an implanted device used to monitor heart and blood vessel activity. |
24 | $33 | $72 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
23 | $130 | $319 |
| Programming of multiple lead implantable defibrillator system Adjustment and testing of the settings for an implanted heart device with multiple leads to ensure proper function. |
20 | $75 | $167 |
| Hospital discharge day management, 30 minutes or less This service covers the final day of hospital care when the patient is being discharged. It includes coordination of care and instructions for the patient within a time frame of 30 minutes or less. |
20 | $63 | $143 |
| Pacemaker programming, single lead Adjustment and testing of a single-lead pacemaker to ensure it functions correctly. |
18 | $53 | $97 |
| Transesophageal echocardiogram An ultrasound of the heart performed using a probe inserted into the esophagus to obtain detailed images of heart structures and function. |
17 | $74 | $484 |
| External shock to heart to regulate heart beat A procedure that delivers an electric shock to the heart from outside the body to restore a normal heart rhythm. |
16 | $79 | $217 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
8.2% high complexity
4.2% medium
87.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$2,044
Total received (2018-2024)
Avg $292/year across 7 years
Bottom 21% in NY for interventional cardiology
28
Companies
129
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,964 (96.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$80 (3.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$312
2023
$66
2022
$13
2021
$97
2020
$153
2019
$1,078
2018
$325
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Merck Sharp & Dohme LLC
$97
Medtronic, Inc.
$72
ABIOMED
$66
Novartis Pharmaceuticals Corporation
$41
Lexicon Pharmaceuticals, Inc.
$19
Janssen Pharmaceuticals, Inc
$17
Top 3 companies account for 75.4% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$259
Amgen Inc.
$248
Janssen Pharmaceuticals, Inc
$216
PFIZER INC.
$170
Boehringer Ingelheim Pharmaceuticals, Inc.
$128
SANOFI-AVENTIS U.S. LLC
$111
ABIOMED
$100
Merck Sharp & Dohme LLC
$97
Medtronic, Inc.
$90
Vifor Pharma, Inc.
$80
Amarin Pharma Inc.
$72
Edwards Lifesciences Corporation
$58
Gilead Sciences, Inc.
$50
Medtronic Vascular, Inc.
$46
AstraZeneca Pharmaceuticals LP
$45
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$38
Boston Scientific Corporation
$36
Regeneron Healthcare Solutions, Inc.
$35
E.R. Squibb & Sons, L.L.C.
$23
Relypsa, Inc.
$22
PORTOLA PHARMACEUTICALS, INC.
$19
Lexicon Pharmaceuticals, Inc.
$19
Bayer HealthCare Pharmaceuticals Inc.
$16
United Therapeutics Corporation
$15
Lantheus Medical Imaging, Inc.
$14
Kowa Pharmaceuticals America, Inc.
$14
BOSTON SCIENTIFIC CORPORATION
$13
Terumo Medical Corporation
$11
Top 3 companies account for 35.4% of all-time payments
Associated products mentioned in payments ›
Adempas · BEVYXXA · BRILINTA · CAMZYOS · CHANTIX · Corlanor · Definity · ELIQUIS · EMBLEM · EMBLEM SICD ELECTRODE DELIVERY SYSTEM · ENTRESTO · Edwards SAPIEN 3 Transcatheter Heart Valve · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · GENERAL TACHY · GENERAL THERAPIES · Impella · JARDIANCE · LEQVIO · LifeVest · Livalo · MICRA · MULTAQ · ORENITRAM · Optitorque · PRADAXA · PRALUENT · Repatha · Reveal LINQ · VYNDAQEL · Vascepa · Veltassa · WINREVAIR · XARELTO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Interventional cardiologists within 10 mi
8
Per 100K population
1.7
County median income
$74,740
Nearest hospital
CROUSE HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Berkery is a clinical cardiology specialist, with above-average Medicare volume (top 13% in NY), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Berkery experienced with anticoagulant management for warfarin?
Based on Medicare claims data, Dr. Berkery performed 903 anticoagulant management for warfarin services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Berkery receive payments from pharmaceutical companies?
Yes. Dr. Berkery received a total of $2,044 from 28 companies across 129 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Berkery's costs compare to other interventional cardiologists in Syracuse?
Dr. Berkery's average Medicare payment per service is $42. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Berkery) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Interventional Cardiologists in Syracuse
Browse interventional cardiologists in Syracuse ranked by procedure volume and transparency data.
Highest volume
Top Interventional Cardiologists in NY
Interventional cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Interventional Cardiologists in NY
Which NY interventional cardiologists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology